First Albany Ups Martek Biosciences to Buy

Analyst David Webber has greater confidence in additional penetration of the food market by Martek this year

First Albany upgraded Martek Biosciences (MATK) to buy from neutral, citing the company's quarterly results.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.